AI in drug discovery
AI in drug discovery is the application of artificial intelligence, machine learning, and deep learning across the pharmaceutical pipeline to identify drug targets, design new molecules, predict protein…
Drug Discovery
Explore Drug Discovery through related topics and the articles other pages reference most.
Most referenced in this topic
Ranked by links from other AI Wiki pages.
Explore articles
Browse subtopics (12)
Articles that also belong to these categories. Counts cover all of Drug Discovery.
Showing 1-32 of 32 articles
AlphaFold 3
AlphaFold 3 is a biomolecular structure prediction system developed jointly by Google DeepMind and Isomorphic Labs and published in Nature on May 8, 2024.
AlphaFold-Multimer
AlphaFold-Multimer is a deep learning system for predicting the three-dimensional structures of protein complexes, released by Google DeepMind in October 2021 as an extension of AlphaFold 2.
AlphaProteo
AlphaProteo is a machine learning system developed by Google DeepMind for the de novo design of high-affinity protein binders, novel proteins that attach tightly to a chosen target.
Basecamp Research
Basecamp Research is a London-based artificial intelligence and biotechnology company that has assembled what it describes as the world's largest and most diverse database of biological sequences, sampled…
Boltz
Boltz is a family of open-source biomolecular structure prediction models developed primarily at MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) and the MIT Jameel Clinic.
Chai Discovery
Chai Discovery is an American AI biotechnology company that builds foundation models for predicting and designing the three-dimensional structures of biomolecules to accelerate drug discovery.
Chai-1
Chai-1 is an open multimodal foundation model for biomolecular structure prediction released by the San Francisco startup Chai Discovery on 9 September 2024.
Claude for Life Sciences
Claude for Life Sciences is an industry-specific offering from Anthropic that adapts its Claude models for scientific research and drug development, packaging connectors to laboratory and literature platforms…
Coefficient Bio
Coefficient Bio was a stealth-stage biotechnology and artificial-intelligence startup that, according to multiple press reports, was acquired by Anthropic in an all-stock deal reported at just over $400…
Cradle
Cradle (legally Cradle Bio B.V., styled cradle.bio) is a Dutch-Swiss software company that builds generative AI tools for protein engineering.
ESM3
ESM3 (Evolutionary Scale Modeling 3) is a frontier multimodal generative language model for biology, released by EvolutionaryScale on June 25, 2024, that was the first model to reason jointly over the…
Enveda
Enveda (Enveda Biosciences, legally Enveda Therapeutics) is an American AI drug discovery company that uses machine learning and high-resolution mass spectrometry to decode the chemistry of nature and turn…
EvolutionaryScale
EvolutionaryScale is an American artificial intelligence company that builds frontier generative models for biology, best known for ESM3, a multimodal generative protein language model that can reason over and…
Formation Bio
Formation Bio (formerly TrialSpark) is an American "AI-native" pharmaceutical company that in-licenses and acquires clinical-stage drug candidates and develops them more efficiently by applying artificial…
Generate Biomedicines
Generate Biomedicines (styled "Generate:Biomedicines," and legally Generate Biomedicines, Inc.) is a clinical-stage biotechnology company that uses generative AI to design novel protein therapeutics, including…
Insilico Medicine
Insilico Medicine is a clinical-stage biotechnology company that uses generative AI to discover disease targets and design small-molecule drugs end to end.
Insitro
Insitro (styled "insitro") is a machine learning-driven drug discovery and development company founded in 2018 by Daphne Koller, the Stanford machine learning professor and Coursera co-founder, and…
IsoDDE
IsoDDE, short for Isomorphic Labs Drug Design Engine, is a unified computational drug design system developed by Isomorphic Labs, the Alphabet subsidiary spun out of Google DeepMind in 2021.
Isomorphic Labs
Isomorphic Labs is a London-based artificial intelligence company that designs small molecule and antibody drugs using deep learning models derived from the AlphaFold family of protein structure predictors.
Latent Labs
Latent Labs is a British and American artificial intelligence company building generative foundation models for protein and molecular design.
Nabla Bio
Nabla Bio is a Boston-based artificial intelligence biotechnology company that designs antibodies and other protein therapeutics computationally, an approach it calls generative protein design.
OpenFold
OpenFold is an open source, trainable, GPU friendly PyTorch reimplementation of AlphaFold 2, developed initially by the AlQuraishi lab at Columbia University and then governed by the OpenFold Consortium
Profluent
Profluent (legally Profluent Bio Inc.) is an American artificial intelligence company that uses large language models and generative AI to design novel proteins and genome editors.
Protein language model
A protein language model (pLM) is a neural network trained on raw amino acid sequences using the same self-supervised objectives that power text models, with individual amino acids serving as tokens instead of…
RFdiffusion
RFdiffusion (short for RoseTTAFold diffusion) is a deep-learning system for de novo protein design developed at the University of Washington Institute for Protein Design (IPD) in David Baker's lab.
Recursion Pharmaceuticals
Recursion Pharmaceuticals (NASDAQ: RXRX) is a clinical-stage TechBio company in Salt Lake City, Utah
Rentosertib
Rentosertib is an investigational oral small-molecule inhibitor of TNIK (TRAF2- and NCK-interacting kinase) developed by Insilico Medicine for idiopathic pulmonary fibrosis (IPF)
RoseTTAFold
RoseTTAFold is a deep-learning system for predicting the three-dimensional structures of proteins from amino acid sequence, developed at the Institute for Protein Design (IPD) at the University of Washington…
TxGemma
TxGemma is a collection of open language models from Google built for therapeutic development and drug discovery.
Waypoint Bio
Waypoint Bio is an AI-native biotechnology company based in New York City that designs cell therapies for solid tumors by combining spatial biology with machine learning and in vivo pooled screening.
Xaira Therapeutics
Xaira Therapeutics is an American AI-driven drug discovery company based in South San Francisco, California, that launched publicly on April 23, 2024 with more than $1 billion in committed capital